147 related articles for article (PubMed ID: 6145770)
1. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
[TBL] [Abstract][Full Text] [Related]
2. Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects.
Sbacchi M; Colombo M; La Regina A; Petrillo P; Tavani A
Life Sci; 1988; 42(21):2079-89. PubMed ID: 3386393
[TBL] [Abstract][Full Text] [Related]
3. Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.
Dragonetti M; Bianchetti A; Sacilotto R; Giudice A; Ferrarese N; Cattaneo C; Manara L
Life Sci; 1983; 33 Suppl 1():477-80. PubMed ID: 6664228
[TBL] [Abstract][Full Text] [Related]
4. Morphine no longer blocks gastrointestinal transit but retains antinociceptive action in diallylnormorphine-pretreated rats.
Tavani A; Bianchi G; Manara L
Eur J Pharmacol; 1979 Oct; 59(1-2):151-4. PubMed ID: 510395
[TBL] [Abstract][Full Text] [Related]
5. Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats.
Notarnicola A; Landi M; Bianchi G; Tavani A
Life Sci; 1983; 33 Suppl 1():481-4. PubMed ID: 6664229
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of gastrointestinal transit by morphine and FK 33-824 in the rat and comparative narcotic antagonist properties of naloxone and its N-methyl quaternary analog.
Manara L; Bianchi G; Fiocchi R; Notarnicola A; Peracchia F; Tavani A
Life Sci; 1982 Sep 20-27; 31(12-13):1271-4. PubMed ID: 6183550
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological actions of levallorphan allyl bromide (CM 32191), a new peripheral narcotic antagonist.
Bianchetti A; Giudice A; Picerno N; Carminati P
Life Sci; 1982 Nov 15-22; 31(20-21):2261-4. PubMed ID: 6186879
[TBL] [Abstract][Full Text] [Related]
8. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
Bianchi G; Fiocchi R; Tavani A; Manara L
Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of gastrointestinal transit by morphine in rats results primarily from direct drug action on gut opioid sites.
Manara L; Bianchi G; Ferretti P; Tavani A
J Pharmacol Exp Ther; 1986 Jun; 237(3):945-9. PubMed ID: 3012075
[TBL] [Abstract][Full Text] [Related]
10. Morphine tissue levels and reduction of gastrointestinal transit in rats. Correlation supports primary action site in the gut.
Bianchi G; Ferretti P; Recchia M; Rocchetti M; Tavani A; Manara L
Gastroenterology; 1983 Oct; 85(4):852-8. PubMed ID: 6193028
[TBL] [Abstract][Full Text] [Related]
11. Different targets for i.v. vs. i.c.v. administered morphine for its effect on colonic motility in dogs.
Fioramonti J; Fargeas MJ; Bueno L
Eur J Pharmacol; 1985 Oct; 117(1):115-20. PubMed ID: 4085540
[TBL] [Abstract][Full Text] [Related]
12. Effect of naloxone-3-glucuronide and N-methylnaloxone on the motility of the isolated rat colon after morphine.
Reber P; Brenneisen R; Flogerzi B; Batista C; Netzer P; Scheurer U
Dig Dis Sci; 2007 Feb; 52(2):502-7. PubMed ID: 17211696
[TBL] [Abstract][Full Text] [Related]
13. Dissociation of morphine withdrawal diarrhea and jumping in mice by the peripherally selective opioid antagonist SR 58002 C.
Bianchetti A; Guidice A; Nava F; Manara L
Life Sci; 1986 Dec; 39(24):2297-303. PubMed ID: 3796195
[TBL] [Abstract][Full Text] [Related]
14. Assays for narcotic antagonist activity in rodents.
Pierson AK
Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
[No Abstract] [Full Text] [Related]
15. Comparative effects of prolyl-leucyl-glycinamide and naloxone on morphine-induced inhibition of gastrointestinal transit.
Pillai NP; Bhargava HN
Pharmacol Biochem Behav; 1984 Sep; 21(3):365-8. PubMed ID: 6149566
[TBL] [Abstract][Full Text] [Related]
16. Central and peripheral inhibitory effects of morphine on intestinal transit in mice.
Wong CL
Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):479-83. PubMed ID: 3747641
[TBL] [Abstract][Full Text] [Related]
17. Quantification of the analgesic activity of narcotic antagonists by a modified hot-plate procedure.
O'Callaghan JP; Holtzman SG
J Pharmacol Exp Ther; 1975 Mar; 192(3):497-505. PubMed ID: 1168252
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of a nociceptive reaction by opioid antagonists in mice.
Jacob JJ; Ramabadran K
Br J Pharmacol; 1978 Sep; 64(1):91-8. PubMed ID: 698486
[TBL] [Abstract][Full Text] [Related]
19. Antagonism of gut, but not central effects of morphine with quaternary narcotic antagonists.
Russell J; Bass P; Goldberg LI; Schuster CR; Merz H
Eur J Pharmacol; 1982 Mar; 78(3):255-61. PubMed ID: 7200037
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
Gistrak MA; Paul D; Hahn EF; Pasternak GW
J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
